These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 6365133)

  • 1. Expression of major histocompatibility antigens and leucocyte infiltration in benign and malignant human breast disease.
    Whitwell HL; Hughes HP; Moore M; Ahmed A
    Br J Cancer; 1984 Feb; 49(2):161-72. PubMed ID: 6365133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of histocompatibility and leucocyte differentiation antigens in normal human colon and in benign and malignant colonic neoplasms.
    Csiba A; Whitwell HL; Moore M
    Br J Cancer; 1984 Nov; 50(5):699-709. PubMed ID: 6238615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens.
    Rowe DJ; Beverley PC
    Br J Cancer; 1984 Feb; 49(2):149-59. PubMed ID: 6365132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer.
    Bhan AK; DesMarais CL
    J Natl Cancer Inst; 1983 Sep; 71(3):507-16. PubMed ID: 6193308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of MHC products and leucocyte differentiation antigens in gynaecological neoplasms: an immunohistological analysis of the tumour cells and infiltrating leucocytes.
    Ferguson A; Moore M; Fox H
    Br J Cancer; 1985 Oct; 52(4):551-63. PubMed ID: 2415145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis.
    Aichinger G; Fill H; Wick G
    Lab Invest; 1985 Feb; 52(2):132-40. PubMed ID: 3881622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of major histocompatibility antigens and nature of inflammatory cellular infiltrate in ovarian neoplasms.
    Kabawat SE; Bast RC; Welch WR; Knapp RC; Bhan AK
    Int J Cancer; 1983 Nov; 32(5):547-54. PubMed ID: 6358053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin.
    Poppema S; Bröcker EB; de Leij L; Terbrack D; Visscher T; Ter Haar A; Macher E; Thé TH; Sorg C
    Clin Exp Immunol; 1983 Jan; 51(1):77-82. PubMed ID: 6219841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
    Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
    Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies against human leucocyte antigens. I. Antibodies against beta-2-microglobulin, immunoglobulin kappa light chains, HLA-DR-like antigens, T8 antigen, T1 antigen, a monocyte antigen, and a pan-leucocyte antigen.
    Horejsí V; Hilgert I; Kristofová H; Bazil V; Bukovský A; Kulhánková J
    Folia Biol (Praha); 1986; 32(1):12-25. PubMed ID: 2422063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
    Nuñez G; Giles RC; Ball EJ; Hurley CK; Capra JD; Stastny P
    J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunohistochemical demonstration of major histocompatibility antigens in the human kidney using monoclonal antibodies.
    Hancock WW; Kraft N; Atkins RC
    Pathology; 1982 Oct; 14(4):409-14. PubMed ID: 6760089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T lymphocyte subsets in human intestinal mucosa: the distribution and relationship to MHC-derived antigens.
    Selby WS; Janossy G; Goldstein G; Jewell DP
    Clin Exp Immunol; 1981 Jun; 44(3):453-8. PubMed ID: 6459893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated cytotoxicity against HLA-D-region products expressed in monocytes and B lymphocytes. IV. Characterization of effector cells using monoclonal antibodies against human T-cell subsets.
    Ball EJ; Stastny P
    Immunogenetics; 1982; 16(2):157-69. PubMed ID: 6216209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different patterns of HLA-DR antigen expression in normal epithelium, hyperplastic and neoplastic malignant lesions of the breast.
    Concha A; Ruiz-Cabello F; Cabrera T; Nogales F; Collado A; Garrido F
    Eur J Immunogenet; 1995 Aug; 22(4):299-310. PubMed ID: 7495782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DR human histocompatibility leukocyte antigens-restricted lymphocyte-monocyte interactions in the release from monocytes of acidic isoferritins that suppress hematopoietic progenitor cells.
    Broxmeyer HE; Juliano L; Lu L; Platzer E; Dupont B
    J Clin Invest; 1984 Apr; 73(4):939-53. PubMed ID: 6231314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunohistological study of leukocyte localization in benign and malignant breast tissue.
    Lwin KY; Zuccarini O; Sloane JP; Beverley PC
    Int J Cancer; 1985 Oct; 36(4):433-8. PubMed ID: 3930410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current research on immunopathology of melanoma: analysis of lymphocyte populations in relation to antigen expression and histological features of melanoma.
    Hersey P; Murray E; Grace J; McCarthy WH
    Pathology; 1985 Jul; 17(3):385-91. PubMed ID: 2866482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of bovine MHC class II antigens identified by monoclonal antibodies.
    Taylor BC; Choi KY; Scibienski RJ; Moore PF; Stott JL
    J Leukoc Biol; 1993 May; 53(5):479-89. PubMed ID: 7684762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ characterization of mononuclear cells in rheumatoid tissues, using monoclonal antibodies. No reduction of T8-positive cells or augmentation in T4-positive cells.
    Førre O; Thoen J; Lea T; Dobloug JH; Mellbye OJ; Natvig JB; Pahle J; Solheim BG
    Scand J Immunol; 1982 Oct; 16(4):315-9. PubMed ID: 6983117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.